The Procurement of a Biomark X9 Microfluidics System

The Food and Drug Administration (FDA) is forecasting the procurement of a Biomark X9 Microfluidics System, a sophisticated equipment likely intended for advanced biological and chemical analysis applications. This contract opportunity falls under the NAICS code 423450, which pertains to medical, dental, and hospital equipment and supplies merchant wholesalers. Although specific solicitation details and location information are not provided, the forecast indicates the agency's intent to acquire this system to support its operational or research needs. Key points of contact for this opportunity include the Cber Acquisition Liaison, reachable via the provided email, while the contracting officer's details remain to be determined. Interested parties can find further information or monitor updates through the FDA's official industry opportunity forecast webpage. This procurement represents a valuable chance for suppliers specializing in high-end microfluidics or biomedical instrumentation to engage with a prominent federal health agency.